Drug Database
Back to search

Czechia· CZ-0025696

INSUMAN BASAL

A insulin (human) product containing insulin human, registered in Czechia by Sanofi-Aventis Deutschland GmbH, Frankfurt am Main. The same ATC class is registered in 11 of our 19 countries.

ATC A10AC01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedINSUMAN BASALATCA10AC01REGISTER NO.CZ-0025696PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about insulin humanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Insulin (human) is registered in 11 of 19 countries.

Countries holding a registration under ATC A10AC01 (insulin (human)), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose
Search insulin (human) products by name

Insulin (human) · ATC A10AC01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
INSULIN HUMAN
Manufacturer
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main
Country
Czechia (CZ)
ATC code
A10AC01
ATC class
Insulin (human)
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

460 interactions on record for insulin (human).

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check insulin (human) against other medicinesHow interaction checks work

Insulin (human) · interactions on record

460 records

  • 15 severe
  • 395 moderate
  • 50 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • PrednisoloneA07EA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Insulin (human) in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insulin (human) products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Huminsulin Basal Kwikpen, Huminsulin Basal Kwikpen Lilly
  • Belgium · Humuline 30/70 Cartridge, Humuline Nph Cartridge
  • Bulgaria · Humulin M3 (Mixture 3), Хумулин N
  • Cyprus · Humulin M3
  • Germany · Huminsulin Basal (Nph), Huminsulin Basal (Nph) Kwikpen
  • Denmark · Humulin Nph, Humulin Nph Kwikpen
  • Estonia · Humulin N, Humulin N Kwikpen
  • Spain · Humulina 30:70, Humulina 30:70 Kwikpen
  • France · Umuline Nph, Umuline Nph Kwikpen
  • United Kingdom (Northern Ireland) · Humulin I (Isophane), Humulin I Kwikpen (Isophane)
  • Greece · Humulin M3, Humulin M3 Kwikpen
  • Croatia · Humulin M3, Humulin N
  • Hungary · Humulin M3 (30/70), Humulin N
  • Ireland · Humulin I (Isophane), Humulin I Kwikpen (Isophane)
  • Italy · Humulin 30/70 (Miscela), Humulin I (Isofano)
  • Lithuania · Humulin N, Humulin N Kwikpen
  • Luxembourg · Humuline 30/70 Cartridge, Humuline Nph Cartridge
  • Latvia · Humulin N, Humulin N Kwikpen
  • Malta · Humulin I (Isophane), Humulin M3 (Mixture 3)
  • Netherlands · Humuline 30/70 Patroon, Humuline Nph Kwikpen
  • Portugal · Humulin M3 (Mistura M3), Humulin Nph
  • Romania · Humulin M3, Humulin M3 Kwikpen
  • Sweden · Humulin Nph, Humulin Nph Kwikpen
  • Slovenia · Humulin M3, Humulin M3 Kwikpen
  • Slovakia · Humulin M3 (30/70) Cartridge, Humulin M3 (30/70) Kwikpen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f38da04c-b3b3-44f3-925e-e82931082ac2
GET /v1/drugs/f38da04c-b3b3-44f3-925e-e82931082ac2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ SUS VIA",
  "source": "sukl",
  "strength": "40IU/ML",
  "pack_size": "5X10ML",
  "substance": "INSULIN HUMAN",
  "cz_kod_sukl": "0025696",
  "product_type": "BT",
  "substance_codes": "4960",
  "registration_state": "R",
  "registration_number": "EU/1/97/030/037"
}
API referenceMCP serverPlans

See everything about insulin (human).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console